217 related articles for article (PubMed ID: 6102877)
1. Sulphasalazine in rheumatoid arthritis.
McConkey B; Amos RS; Durham S; Forster PJ; Hubball S; Walsh L
Br Med J; 1980 Feb; 280(6212):442-4. PubMed ID: 6102877
[TBL] [Abstract][Full Text] [Related]
2. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
[TBL] [Abstract][Full Text] [Related]
3. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
Porter D; Madhok R; Hunter JA; Capell HA
Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
[TBL] [Abstract][Full Text] [Related]
4. Salazopyrin in rheumatoid arthritis.
McConkey B; Amos RS; Butler EP; Crockson RA; Crockson AP; Walsh L
Agents Actions; 1978 Jun; 8(4):438-41. PubMed ID: 28650
[TBL] [Abstract][Full Text] [Related]
5. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
[TBL] [Abstract][Full Text] [Related]
6. History of the development of sulphasalazine in rheumatology.
McConkey B
Drugs; 1986; 32 Suppl 1():12-7. PubMed ID: 2877849
[No Abstract] [Full Text] [Related]
7. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
Pullar T; Hunter JA; Capell HA
Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
[TBL] [Abstract][Full Text] [Related]
8. A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.
Farr M; Waterhouse L; Johnson AE; Kitas GD; Jubb RW; Bacon PA
Clin Rheumatol; 1995 Sep; 14(5):531-6. PubMed ID: 8549091
[No Abstract] [Full Text] [Related]
9. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
Crilly A; Madhok R; Watson J; Capell HA
Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
[TBL] [Abstract][Full Text] [Related]
10. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
Martin L; Sitar DS; Chalmers IM; Hunter T
J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A protein during the treatment of rheumatoid arthritis with second-line drugs.
Grindulis KA; Scott DL; Robinson MW; Bacon PA; McConkey B
Br J Rheumatol; 1985 May; 24(2):158-63. PubMed ID: 2859902
[TBL] [Abstract][Full Text] [Related]
12. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
Bax DE; Amos RS
Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.
J Rheumatol; 1992 Nov; 19(11):1672-7. PubMed ID: 1362778
[TBL] [Abstract][Full Text] [Related]
14. Sulphasalazine in the treatment of rheumatoid arthritis.
Pelísková Z; Vácha J; Trnavský K
Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
[TBL] [Abstract][Full Text] [Related]
15. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
Delamere JP; Farr M; Grindulis KA
Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
[No Abstract] [Full Text] [Related]
16. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
Chakravarty K; Scott DG; McCann BG
Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
[TBL] [Abstract][Full Text] [Related]
17. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
[TBL] [Abstract][Full Text] [Related]
18. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.
Marouf ES; Morris IM
Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490
[No Abstract] [Full Text] [Related]
19. Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?
Capell HA; Porter DR; Madhok R; Hunter JA
Ann Rheum Dis; 1993 Jun; 52(6):423-8. PubMed ID: 8100702
[TBL] [Abstract][Full Text] [Related]
20. Which component of sulphasalazine is active in rheumatoid arthritis?
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
